✦ LIBER ✦

Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib

✍ Scribed by M. Breccia; I. Carmosino; E. Russo; S. G. Morano; R. Latagliata; G. Alimena

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early blastic transformation with CNS in

✍ Jiri Pavlu; Barbara Czepulkowski; Richard Kaczmarski; Riaz Jan-Mohamed 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 84 KB

Dendritic cells become BCR–ABL negative

✍ Wang, L; Butt, N M; Atherton, M G; Clark, R E 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Prognostic factors for patients with chr

✍ Marin, D; Marktel, S; Bua, M; Szydlo, R M; Franceschino, A; Nathan, I; Foot, N; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Suboptimal response in chronic myeloid l

✍ Massimo Breccia; Giuliana Alimena 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Predictive factors for successful imatin

✍ Lee, Sung-Eun; Choi, Soo Young; Bang, Ju-Hee; Kim, Soo-Hyun; Jang, Eun-jung; Bye 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

Cross-intolerance to imatinib, dasatinib

✍ Igor Novitzky-Basso; Charles Craddock 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB